ArticleWorld journal of surgical oncology2016
Primary intracranial neuroendocrine tumor: two case reports.
Article in World journal of surgical oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 26 citations in OpenAlex.
- Case report of intracranial neuroendocrine carcinoma.Frontiers in oncology · 2026Article
- The "chameleon" sellar lesions: a case report of unexpected sellar lesions.Frontiers in neurology · 2023Article
- Primary Neuroendocrine Carcinoma of the Cerebellopontine Angle: A Case Report and Literature Review.Cureus · 2022Article
- Unique Finding of a Primary Central Nervous System Neuroendocrine Carcinoma in a 5-Year-Old Child: A Case Report.Frontiers in neuroscience · 2022Article
- Primary neuroendocrine tumor of the pineal gland: a case report.BMC neurology · 2021Article
- Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?Journal of the Endocrine Society · 2021Article
- Unusual cause of a painless soft tissue mass of the scalp: a rare presentation of primary intracranial neuroendocrine neoplasm.BMJ case reports · 2021Review
- Primary Intracranial Neuroendocrine Tumor of the Skull Base Complicated with Tension Pneumocephalus after Radiotherapy.NMC case report journal · 2021Article
- Primary skull base neuroendocrine carcinoma-a case report and review of literature.Radiology case reports · 2020Article
- Canine adrenocorticotropic hormone-producing sinusoidal neuroendocrine tumor associated with Cushing's disease.The Journal of veterinary medical science · 2019Article
- A tale of pituitary adenomas: to NET or not to NET : Pituitary Society position statement.Pituitary · 2019Review
- Primary neuroendocrine carcinoma of the brain.BMJ case reports · 2019Article
- Primary pituitary neuroendocrine tumor: Case report and literature review.Surgical neurology international · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeuroendocrine tumor originates from the diffuse neuroendocrine system. Intracranial originating is lower to 0.74 %. CASE PRESENTATION: We present two cases of primary intracranial neuroendocrine tumor A 39-year-old woman was admitted with headache, fever, polydipsia and polyuria. Biochemical and endocrinological results showed hyponatremia, hypothyroidism and hypopituitarism. MRI scans demonstrated an obviouslyenhancing lesion in seller and superseller area. Then a gross removal of tumor was achieved during the single nostril transsphenoidal approach surgery. Pathological diagnosis was high-grade small-cell neuroendocrine tumor. A 40-year-old woman presented with multiple symptoms and neurological deficit. Neuroimaging results demonstrated a huge obviously-enhancing tumor in anterior cranial fossa. Biochemical and hormone findings revealed hypokalemia, high glucose and hypercortisolemia. The intracranial surgery achieved a gross removal through a right frontal craniotomy. Pathological diagnosis was low-grade small-cell neuroendocrine tumor with immuno-negativity for ACTH.
conclusionThe mechanism, diagnosis, and treatment of neuroendocrine tumor are still challenging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.